Shettys Pharmaceuticals And Biologicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 79 Year, 3 Months
- Open Charges ₹ 0.15 M
About Shettys Pharmaceuticals And Biologicals
Shettys Pharmaceuticals And Biologicals Limited (SPABL) was founded in India on 02 November 1945 and has a glorious history of 79 years and three months.Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.15 M.
Boddupalli Srinivas, John, and Nagesh Mamilla serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1945PLC001324
- Company No.
001324
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Nov 1945
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shettys Pharmaceuticals And Biologicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Boddupalli Srinivas  | Director | 01-Jul-2007 | Current |
| John | Director | 01-Jul-2007 | Current |
| Nagesh Mamilla | Director | 01-Jul-2007 | Current |
Financial Performance of Shettys Pharmaceuticals And Biologicals.
Enhance accessibility to Shettys Pharmaceuticals And Biologicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shettys Pharmaceuticals And Biologicals?
Unlock access to Shettys Pharmaceuticals And Biologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.15 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 1984 | Corporation Bank | ₹0.15 M | Open |
How Many Employees Work at Shettys Pharmaceuticals And Biologicals?
Unlock and access historical data on people associated with Shettys Pharmaceuticals And Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shettys Pharmaceuticals And Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shettys Pharmaceuticals And Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.